Spinal fluid test may forecast MS severity
NCT ID NCT05072691
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether measuring certain proteins (free light chains) in spinal fluid can help predict how multiple sclerosis (MS) will progress. Researchers will follow 100 people with MS or optic neuritis, tracking their disability, relapses, and vision recovery. The goal is to find a better way to guide treatment decisions early in the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict how multiple sclerosis will progress and choose the best treatment early on.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find a clear link, and results may not apply to all MS patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Brugmann
RECRUITINGBrussels, 1020, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?